Biblio
Export 1382 results:
Author Title [ Type
Filters: First Letter Of Last Name is G [Clear All Filters]
“Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1289-1294, 2018.
, “Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.”, J Alzheimers Dis, vol. 54, no. 2, pp. 525-33, 2016.
, “PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.”, J Alzheimers Dis, vol. 50, no. 2, pp. 353-7, 2016.
, “PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.”, J Alzheimers Dis, vol. 50, no. 2, pp. 353-7, 2016.
, “PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.”, J Alzheimers Dis, vol. 50, no. 2, pp. 353-7, 2016.
, “Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1459-1471, 2016.
, “Primary cortical cell tri-culture to study effects of amyloid-β on microglia function and neuroinflammatory response.”, J Alzheimers Dis, vol. 102, no. 3, pp. 730-741, 2024.
, “Primary cortical cell tri-culture to study effects of amyloid-β on microglia function and neuroinflammatory response.”, J Alzheimers Dis, vol. 102, no. 3, pp. 730-741, 2024.
, “Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research.”, J Alzheimers Dis, vol. 95, no. 3, pp. 753-768, 2023.
, “Prevalence, Risk Factors, and Complaints Screening Tool Exploration of Subjective Cognitive Decline in a Large Cohort of the Chinese Population.”, J Alzheimers Dis, vol. 60, no. 2, pp. 371-388, 2017.
, “Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1639-1652, 2018.
, “Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective Study.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1179-1187, 2022.
, “Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective Study.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1179-1187, 2022.
, “Prevalence and Risk Factor of Cognitive Impairment were Different between Urban and Rural Population: A Community-Based Study.”, J Alzheimers Dis, vol. 49, no. 4, pp. 917-25, 2016.
, “Prevalence and Determinants of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients Screened Positive for Dementia: Results from the Population-Based DelpHi-Study.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1091-1097, 2018.
, “Present Algorithms and Future Treatments for Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 4, pp. 1157-1171, 2019.
, “The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 345-56, 2016.
, “A Preliminary Study on the Feasibility of Using a Virtual Reality Cognitive Training Application for Remote Detection of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 2, pp. 619-627, 2017.
, “Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1099-109, 2016.
, “Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.”, J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
, “Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.”, J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
, “Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 2, pp. 717-728, 2018.
, “Predictors and Moderators of Quality of Life in Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1113-1121, 2016.
, “Predictors and Moderators of Quality of Life in Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1113-1121, 2016.
, “Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1045-56, 2016.
,